117 related articles for article (PubMed ID: 2211203)
21. Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies.
Kim HK; Silver B; Li S; Neuberg D; Mauch P
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):556-60. PubMed ID: 12738333
[TBL] [Abstract][Full Text] [Related]
22. Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Zanini M; Viviani S; Santoro A; Soncini F; Bonfante V; Devizzi L; Villani F; Castellani MR; Negretti E; Zucali R
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):813-9. PubMed ID: 7525516
[TBL] [Abstract][Full Text] [Related]
23. Radical treatment of Hodgkin disease with radiation therapy: results of a 15-year clinical trial. The 1985 Erskine lecture.
Levitt SH; Lee CK; Aeppli DM; Bloomfield CD
Radiology; 1987 Mar; 162(3):623-30. PubMed ID: 3544029
[TBL] [Abstract][Full Text] [Related]
24. Hodgkin's disease: a reassessment of prognostic factors following modification of radiotherapy.
Lee CK; Aeppli DM; Bloomfield CD; Levitt SH
Int J Radiat Oncol Biol Phys; 1987 Jul; 13(7):983-91. PubMed ID: 3597162
[TBL] [Abstract][Full Text] [Related]
25. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
[TBL] [Abstract][Full Text] [Related]
26. Cure of early-stage Hodgkin's disease with subtotal nodal irradiation.
Wasserman TH; Trenkner DA; Fineberg B; Kucik N
Cancer; 1991 Sep; 68(6):1208-15. PubMed ID: 1873772
[TBL] [Abstract][Full Text] [Related]
27. Hodgkin's disease. Results from a program in radiation therapy.
Micaily B; Brady LW
Am J Clin Oncol; 1984 Apr; 7(2):159-71. PubMed ID: 6422736
[TBL] [Abstract][Full Text] [Related]
28. Results of lung irradiation for Hodgkin's disease patient with large mediastinal masses and/or hilar disease.
Lee CK; Bloomfield CD; Levitt SH
Cancer Treat Rep; 1982 Apr; 66(4):819-25. PubMed ID: 7074653
[TBL] [Abstract][Full Text] [Related]
29. The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Levi JA; Wiernik PH
Cancer; 1977 May; 39(5):2158-65. PubMed ID: 404027
[TBL] [Abstract][Full Text] [Related]
30. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
31. Radiation therapy for early stage Hodgkin's disease: Australasian patterns of care. Australasian Radiation Oncology Lymphoma Group.
Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Liew KH; Morgan G
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):227-36. PubMed ID: 7836074
[TBL] [Abstract][Full Text] [Related]
32. Long-term (15 years) results of extended field radiotherapy in Hodgkin's disease.
Sevcíková EL; Boljesíková E; Chorváth M; Kovacicová G
Neoplasma; 2000; 47(4):253-6. PubMed ID: 11043832
[TBL] [Abstract][Full Text] [Related]
33. Two cycles of MOPP and radiotherapy for stage III1A and stage III1B Hodgkin's disease.
Henkelmann GC; Hagemeister FB; Fuller LM
J Clin Oncol; 1988 Aug; 6(8):1293-302. PubMed ID: 3411342
[TBL] [Abstract][Full Text] [Related]
34. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.
Carde P; Burgers JM; Henry-Amar M; Hayat M; Sizoo W; Van der Schueren E; Monconduit M; Noordijk EM; Lustman-Marechal J; Tanguy A
J Clin Oncol; 1988 Feb; 6(2):239-52. PubMed ID: 2578012
[TBL] [Abstract][Full Text] [Related]
35. Second malignant neoplasms in patients treated for Hodgkin's disease with radiotherapy or radiotherapy and chemotherapy.
Nelson DF; Cooper S; Weston MG; Rubin P
Cancer; 1981 Dec; 48(11):2386-93. PubMed ID: 7296488
[TBL] [Abstract][Full Text] [Related]
36. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.
Mauch P; Tarbell N; Weinstein H; Silver B; Goffman T; Osteen R; Zajac A; Coleman CN; Canellos G; Rosenthal D
J Clin Oncol; 1988 Oct; 6(10):1576-83. PubMed ID: 3171625
[TBL] [Abstract][Full Text] [Related]
37. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy results in laparotomy-staged Hodgkin's disease.
Verger E; Easton D; Brada M; Duchesne G; Horwich A
Clin Radiol; 1988 Jul; 39(4):428-31. PubMed ID: 3180656
[TBL] [Abstract][Full Text] [Related]
39. Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980).
Cornbleet MA; Vitolo U; Ultmann JE; Golomb HM; Oleske D; Griem ML; Ferguson DJ; Miller JB
J Clin Oncol; 1985 Jun; 3(6):758-68. PubMed ID: 4009215
[TBL] [Abstract][Full Text] [Related]
40. Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.
Press OW; LeBlanc M; Lichter AS; Grogan TM; Unger JM; Wasserman TH; Gaynor ER; Peterson BA; Miller TP; Fisher RI
J Clin Oncol; 2001 Nov; 19(22):4238-44. PubMed ID: 11709567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
